Indications

Applicable to postmenopausal women with advanced breast cancer. Of estrogen receptor -negative patients, if their tamoxifen showed positive clinical response, consider using this. It is suitable for postmenopausal women with hormone receptor -positive adjuvant treatment of early breast cancer. Also could be applied for whom have received 2 to 3 years after he tamoxifen adjuvant treatment of postmenopausal female patient in the adjuvant treatment of hormone receptor positive early breast cancer.